Purpose: To report a rare case of atypical fibroxanthoma (AFX) of the bulbar conjunctiva, and to compare it with previously published cases of conjunctival AFX.
A typical fibroxanthoma (AFX) is an uncommon, usually painless, rapidly enlarging tumor that most commonly occurs in the skin (dermis) of the head and neck of older individuals. 1, 2 Only rarely has AFX been reported in the eyelid [3] [4] [5] or conjunctiva. [6] [7] [8] [9] We describe an AFX arising on the bulbar conjunctiva near the corneal limbus.
CASE REPORT
A 37-year-old woman developed a growth on the bulbar conjunctiva of her left eye that increased in size and redness over 4 months. She noted blurry vision in the left eye, occasional diplopia, irritation of the eye, and increasing tearing. Slit-lamp examination disclosed a highly vascularized conjunctival lesion with intact lustrous epithelium and a raised nodular edge encroaching on the nasal corneal limbus of the left eye (Fig. 1) . Gentle prodding of the lesion during clinical examination suggested that it was tethered to deeper tissue. The lesion was not attached to underlying sclera at surgery; it was completely excised with a 3-mm margin, mitomycin C 0.04% was applied to the sclera and Tenon capsule for 90 seconds, and double freeze-thaw cryotherapy was applied to the conjunctival border. An amniotic membrane graft was placed over the remaining conjunctival defect.
PATHOLOGY
Histological sections revealed conjunctiva with superficial keratinization of the epithelium overlying a tumor in the substantia propria separated from the epithelium by a thin layer of normal tissue ( Fig. 2A) . The tumor, which measured approximately 7 · 5 · 3 mm, featured numerous multinucleated giant cells with oval nuclei, medium-size nucleoli, and eosinophilic cytoplasm, often with one or more, large, empty, cytoplasmic vacuoles (Fig. 2B) . Interspersed with the multinucleated giant cells were histiocyte-like cells with oval vesicular nuclei, medium-size to large eosinophilic nucleoli, and pale pink cytoplasm with indistinct cytoplasmic borders (Fig. 2B) . A subpopulation of tumor cells, approximately 10%-20%, were spindle shaped with elongated vesicular nuclei, small nucleoli, and indistinct cytoplasm (Fig. 2C ). Numerous mitotic figures were present in the histiocyte-like cells (Fig. 2D) . The tumor cells were mostly contiguous, with only a few areas where tumor cells were separated by brightly eosinophilic, hyalinized stroma (Fig. 2C) . The edges of the tumor were circumscribed, the lateral edges were free of tumor, although tumor cells contacted the deep margin of resection. All of the tumor cells expressed CD10 on their cell membranes (Fig. 2E ) and vimentin in their cytoplasm (Fig.  2F) . Interdigitating among the tumor cells were dendriticshaped, nonneoplastic cells expressing CD163, a marker for histiocytes and dendritic cells (Fig. 2G) . A few cells expressing S-100 protein, another marker for dendritic cells, were also detected among the neoplastic cells (Fig. 2H) , similar to previous reports.
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DISCUSSION
AFX is of uncertain histogenesis and is characterized histologically by a mixture of atypical histiocyte-like (epithelioid) cells, spindle-cells, and multinucleated giant cells; numerous mitoses, some of which may be atypical; and intracytoplasmic lipid vacuoles in some cells. 2, 10 The most frequent morphological pattern in the skin is a mixture of spindle-cells and histiocyte-like epithelioid cells; the second most common is composed mostly of spindle-cells; whereas predominant histiocyte-like (epithelioid) cells, as in our patient, are the least common. 10 AFX tumor cells exhibit membrane expression of CD10 and cytoplasmic vimentin, as in the present case. 1,2 CD10, a neutral endopeptidase expressed on many types of benign and malignant cells, is coexpressed with vimentin in a variety of other tumors, including sarcomas, certain renal cell carcinomas, neurothekeomas, and nodular fasciitis (http://www.immunoquery.com); these must be excluded based on morphology, clinical history, and examination (such as the absence of a primary tumor elsewhere), and sometimes additional immunohistochemical stains. 2, 10 Histiocytic and dendritic cell markers, such as CD163 and S100 protein in this case, may also be positive in AFX and are considered to be staining nonneoplastic infiltrating cells.
Despite the common presence of tumor cells with bizarre, malignant-appearing cytological features, AFX of the skin has a low recurrence rate if completely excised and rarely, if ever, metastasizes.
1,2 The recurrence rate of skin AFX is estimated to be 5% or less, 1 whereas putative cases of metastatic skin AFX are believed to be malignant fibrous histiocytomas that were misclassified as AFX. 1, 2 AFX has been reported only rarely in the eyelid 3-5 or conjunctiva. [6] [7] [8] [9] Three of the conjunctival AFX cases involved the bulbar conjunctiva at the limbus 6, 7, 9 and one was in the palpebral conjunctiva. 8 Previous cases of AFX of the bulbar conjunctiva were in a 5 and 1/2-year-old boy with xeroderma pigmentosum, 5 and men aged 59 8 and 81. 6 The sole case of AFX reported in the palpebral conjunctiva was in a 94-yearold woman. 8 Previous conjunctival AFX cases have been either spindle-cell predominant 7, 9 or more pleomorphic with numerous histocyte-like (epithelioid) cells and multinucleated giant cells, as in our patient. 6, 8 Treatment of conjunctival AFX relies on complete excision, 7 similar to therapy for skin AFX. 1 Incomplete excision may result in local tumor recurrence. 1, 7 Too few cases of conjunctival AFX have been reported to know whether there is any metastatic potential, but this seems extremely unlikely based on the biological behavior of skin AFX.
